Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
IASLC WCLC 2026
2026 ASCO GI
ASCO Breakthrough 2026
ASCO 2026
ESTRO 2026
Calendar
View All
Topics
AI in Oncology
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
2017 APOS Annual Conference,2017 APOS Annual Conference
«
1
»
Advertisement
Advertisement
Sep
21
Today In Oncology
TMC-I Regimen May Expand Treatment Access in Advanced Head and Neck Cancer
Mobile CT Lung Cancer Screening May Expand Access for Underserved Populations
ASTRO Issues Its First Clinical Guideline on Radiation Therapy for Bladder Cancer
Losing Weight and Breast Cancer Risk? The GLP-1 Question
FDA Approves Imlunestrant in Combination With Abemaciclib for ER-Positive, HER2-Negative, ESR1-Mutated Advanced or Metastatic Breast Cancer
View More
Advertisement
